Abstract
Flow cytometry (FCM) is a powerful technology that can provide rapid multiparameter analysis of single cells. With the significant improvement in instrumentation and reagents during the past several decades, multicolor FCM can quickly analyze lymphoid and hematopoietic cells and plays a critically important role in the diagnosis of most hematolymphoid neoplasms. Being able to rapidly identify abnormal blast populations and give blast lineage classification, FCM study is indispensable for the diagnosis and posttreatment monitoring of acute leukemia. With the ability of highly efficient immunoty** and clonality assessment for mature B-cells and mature αβ T-cells, FCM can quickly characterize the phenotype of an abnormal lymphoid population, make the diagnosis, or assist in the classification of a mature lymphoid neoplasm. In addition, FCM study can sensitively detect the phenotypic abnormalities of myeloid cells and erythroid precursors in patients with myelodysplastic syndrome or other myeloid neoplasms. FCM can readily measure DNA content and determine the DNA ploidy of a cell population, which is useful for making a diagnosis and/or predicting prognosis. FCM study is also useful in the identification of the malignant cells of non-hematologic malignancies, especially in liquid specimens such as bone marrow, body fluid, and fine needle aspiration. Correlation with histomorphologic features, clinical information, and sometimes cytogenetic/molecular findings is always required for accurate interpretation of FCM results. This chapter provides an overview of the principles and some advances of FCM in the diagnosis of hematological neoplasms and other cancers.
Similar content being viewed by others
References
Acosta M, Pereira J, Arroz M (2016) Screening of carcinoma metastasis by flow cytometry: a study of 238 cases. Cytometry B Clin Cytom 90(3):289–294. https://doi.org/10.1002/cyto.b.21258. Epub 2015 Jul 7. PMID: 26054018
Adan A, Alizada G, Kiraz Y et al (2017) Flow cytometry: basic principles and applications. Crit Rev Biotechnol 37(2):163–176. https://doi.org/10.3109/07388551.2015.1128876. Epub 2016 Jan 14. PMID: 26767547
Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720–1748. https://doi.org/10.1038/s41375-022-01620-2. Epub 2022 Jun 22. PMID: 35732829; PMCID: PMC9214472
Amador-Ortiz C, Goolsby CL, Peterson LC et al (2015) Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Clin Pathol 143(2):214–222. https://doi.org/10.1309/AJCPT32JDFIGHFHJ. PMID: 25596247
Annunziata J, Miller ML, Park DC et al (2020) Detection of nonhematologic neoplasms by routine flow cytometry analysis. Am J Clin Pathol 153(1):99–104. https://doi.org/10.1093/ajcp/aqz138. PMID: 31587038
Bento LC, Correia RP, Pitangueiras Mangueira CL et al (2017) The use of flow cytometry in myelodysplastic syndromes: a review. Front Oncol 7:270. https://doi.org/10.3389/fonc.2017.00270. PMID: 29188193; PMCID: PMC5694750
Berg H, Otteson GE, Corley H et al (2021) Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms. Cytometry B Clin Cytom 100(3):361–369. https://doi.org/10.1002/cyto.b.21881. Epub 2020 Apr 25. PMID: 32333725
Borowitz MJ, Guenther KL, Shults KE et al (1993) Immunophenoty** of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 100(5):534–540. https://doi.org/10.1093/ajcp/100.5.534. PMID: 8249893
Campbell JJ, Clark RA, Watanabe R et al (2010) Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 116:767–771. PMID: 20484084
Cessna MH, Hartung L, Tripp S et al (2005) Hairy cell leukemia variant: fact or fiction. Am J Clin Pathol 123(1):132–138. https://doi.org/10.1309/8qytyq1clqmhq9cl. PMID: 15762289
Chang A, Benda PM, Wood BL et al (2003) Lineage-specific identification of nonhematopoietic neoplasms by flow cytometry. Am J Clin Pathol 119(5):643–655. https://doi.org/10.1309/FU3F-DKYN-8AU0-891N. PMID: 12760282
Chen X, Cherian S (2017) Acute myeloid leukemia immunophenoty** by flow cytometric analysis. Clin Lab Med 37(4):753–769. https://doi.org/10.1016/j.cll.2017.07.003. Epub 2017 Aug 31. PMID: 29128067
Craig JW, Dorfman DM (2017) Flow cytometry of T cells and T-cell neoplasms. Clin Lab Med 37(4):725–751. https://doi.org/10.1016/j.cll.2017.07.002. Epub 2017 Oct 3. PMID: 29128066
Craig FE, Foon KA (2008) Flow cytometric immunophenoty** for hematologic neoplasms. Blood 111(8):3941–3967. https://doi.org/10.1182/blood-2007-11-120535. Epub 2008 Jan 15. PMID: 18198345
Danielsen HE, Pradhan M, Novelli M (2016) Revisiting tumour aneuploidy – the place of ploidy assessment in the molecular era. Nat Rev Clin Oncol 13(5):291–304. https://doi.org/10.1038/nrclinonc.2015.208. Epub 2015 Nov 24. PMID: 26598944
Davidson B (2016) Malignant nonhematological effusion characterization by flow cytometry. Acta Cytol 60(4):365–371. https://doi.org/10.1159/000447687. Epub 2016 Aug 18. PMID: 27532128
Della Porta MG, Picone C, Pascutto C et al (2012) Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study. Haematologica 97(8):1209–1217. https://doi.org/10.3324/haematol.2011.048421. Epub 2012 Feb 7. PMID: 22315489; PMCID: PMC3409819
DiGiuseppe JA, Wood BL (2019) Applications of flow cytometric immunophenoty** in the diagnosis and posttreatment monitoring of B and T lymphoblastic leukemia/lymphoma. Cytometry B Clin Cytom 96(4):256–265. https://doi.org/10.1002/cyto.b.21833. Epub 2019 Jun 24. PMID: 31231940
Duetz C, Westers TM, van de Loosdrecht AA (2019) Clinical implication of multi-parameter flow cytometry in myelodysplastic syndromes. Pathobiology 86(1):14–23. https://doi.org/10.1159/000490727. Epub 2018 Sep 18. PMID: 30227408; PMCID: PMC6482988
Eidenschink Brodersen L, Alonzo TA, Menssen AJ et al (2016) A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children’s Oncology Group. Leukemia 30(10):2077–2080. https://doi.org/10.1038/leu.2016.119. Epub 2016 May 2. PMID: 27133823; PMCID: PMC5136463
Escribano L, Garcia Montero AC, Núñez R et al (2006) Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell disease. Immunol Allergy Clin N Am 26(3):535–547. https://doi.org/10.1016/j.iac.2006.05.008. PMID: 16931292
Grewal RK, Chetty M, Abayomi EA et al (2019) Use of flow cytometry in the phenotypic diagnosis of Hodgkin’s lymphoma. Cytometry B Clin Cytom 96(2):116–127. https://doi.org/10.1002/cyto.b.21724. Epub 2018 Oct 22. PMID: 30350336
Gupta S, Karandikar NJ, Ginader T, Bellizzi AM, Holman CJ (2018) Flow cytometric aberrancies in plasma cell myeloma and MGUS - correlation with laboratory parameters. Cytometry B Clin Cytom 94(3):500–508. https://doi.org/10.1002/cyto.b.21624. Epub 2018 Jan 23. PMID: 29316245; PMCID: PMC6342462
Guy J, Antony-Debré I, Benayoun E et al (2013) Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia. Br J Haematol 161(4):551–555. https://doi.org/10.1111/bjh.12277. Epub 2013 Feb 25. PMID: 23432206
Horna P, Shi M, Olteanu H, Johansson U (2021) Emerging role of T-cell receptor constant β chain-1 (TRBC1) expression in the flow cytometric diagnosis of T-cell malignancies. Int J Mol Sci 22(4):1817. https://doi.org/10.3390/ijms22041817. PMID: 33673033; PMCID: PMC7918842
Jain N, Lamb AV, O’Brien S et al (2016) Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood 127(15):1863–1869. https://doi.org/10.1182/blood-2015-08-661702. Epub 2016 Jan 8. PMID: 26747249; PMCID: PMC4915808
Julia F, Dalle S, Duru G et al (2014) Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients. Am J Surg Pathol 38(5):673–680. https://doi.org/10.1097/PAS.0000000000000156. PMID: 24441662
Kentrou NA, Tsagarakis NJ, Tzanetou K et al (2011) An improved flow cytometric assay for detection and discrimination between malignant cells and atypical mesothelial cells, in serous cavity effusions. Cytometry B Clin Cytom 80(5):324–334. https://doi.org/10.1002/cyto.b.20608. Epub 2011 Jun 21. PMID: 21695775
Kern W, Bacher U, Schnittger S et al (2013) Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms. Cytometry B Clin Cytom 84(3):194–197. https://doi.org/10.1002/cyto.b.21068. Epub 2013 Jan 2. PMID: 23283847
Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms. Leukemia 36(7):1703–1719. https://doi.org/10.1038/s41375-022-01613-1. Epub 2022 Jun 22. PMID: 35732831; PMCID: PMC9252913
Kroft SH (2004) Monoclones, monotypes, and neoplasia pitfalls in lymphoma diagnosis. Am J Clin Pathol 121(4):457–459. https://doi.org/10.1309/RR8A-XUWM-9FYX-178A. PMID: 15080295
Li W, Chastain K (2018) NUT midline carcinoma with leukemic presentation mimicking CD34-positive acute leukemia. Blood 132(4):456. https://doi.org/10.1182/blood-2017-07-796268. PMID: 30049733
Li W, Morgan R, Nieder R et al (2021) Normal or reactive minor cell populations in bone marrow and peripheral blood mimic minimal residual leukemia by flow cytometry. Cytometry B Clin Cytom 100(5):590–601. https://doi.org/10.1002/cyto.b.21968. Epub 2020 Nov 16. PMID: 33197125
Lin P, Owens R, Tricot G, Wilson CS (2004) Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 121(4):482–488. https://doi.org/10.1309/74R4-TB90-BUWH-27JX. PMID: 15080299
Loken MR, van de Loosdrecht A, Ogata K et al (2008) Flow cytometry in myelodysplastic syndromes: report from a working conference. Leuk Res 32(1):5–17. https://doi.org/10.1016/j.leukres.2007.04.020. Epub 2007 Jun 18. PMID: 17576013
Mathis S, Chapuis N, Debord C et al (2013) Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes. Leukemia 27(10):1981–1987. https://doi.org/10.1038/leu.2013.178. Epub 2013 Jun 14. PMID: 23765225
McKenna RW, Asplund SL, Kroft SH (2004) Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry. Leuk Lymphoma 45(2):277–285. https://doi.org/10.1080/1042819031000151950. PMID: 15101712
McKinnon KM (2018) Flow cytometry: an overview. Curr Protoc Immunol 120:5.1.1–5.1.11. https://doi.org/10.1002/cpim.40. PMID: 29512141; PMCID: PMC5939936
Menter T, Dirnhofer S, Tzankov A (2015) LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma. J Clin Pathol 68(6):473–478. https://doi.org/10.1136/jclinpath-2015-202862. Epub 2015 Feb 24. PMID: 25713417
Morice WG, Kurtin PJ, Leibson PJ, Tefferi A, Hanson CA (2003) Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 120(6):1026–1036. https://doi.org/10.1046/j.1365-2141.2003.04201.x. PMID: 12648073
Ouyang J, Zheng W, Shen Q et al (2015) Flow cytometry immunophenotypic analysis of Philadelphia-negative myeloproliferative neoplasms: correlation with histopathologic features. Cytometry B Clin Cytom 88(4):236–243. https://doi.org/10.1002/cyto.b.21215. Epub 2014 Dec 30. PMID: 25557358
Pillai V, Dorfman DM (2016) Flow cytometry of nonhematopoietic neoplasms. Acta Cytol 60(4):336–343. https://doi.org/10.1159/000448371. Epub 2016 Aug 27. PMID: 27578265
Porwit A, van de Loosdrecht AA, Bettelheim P et al (2014) Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS. Leukemia 28(9):1793–1798. https://doi.org/10.1038/leu.2014.191. Epub 2014 Jun 12. PMID: 24919805
Raja KR, Kovarova L, Hajek R (2010) Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders. Br J Haematol 149(3):334–351. https://doi.org/10.1111/j.1365-2141.2010.08121.x. Epub 2010 Mar 1. PMID: 20201947
Roberts KG, Li Y, Payne-Turner D et al (2014) Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med 371(11):1005–1015. https://doi.org/10.1056/NEJMoa1403088. PMID: 25207766; PMCID: PMC4191900
Ryan ME, Baldauf MC (1994) Comparison of flow cytometry for DNA content and brush cytology for detection of malignancy in pancreaticobiliary strictures. Gastrointest Endosc 40(2 Pt 1):133–139. https://doi.org/10.1016/s0016-5107(94)70154-7. PMID: 8013809
Sánchez-Muñoz L, Teodósio C, Morgado JM et al (2011) Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders. Methods Cell Biol 103:333–359. https://doi.org/10.1016/B978-0-12-385493-3.00014-0. PMID: 21722810
Sandes AF, de Lourdes Chauffaille M, Oliveira CR et al (2014) CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry. Cytometry B Clin Cytom 86(2):98–105. https://doi.org/10.1002/cyto.b.21128. Epub 2013 Oct 8. PMID: 24243815
Sawada T, Matsumura T (2000) DNA ploidy and prognosis of neuroblastoma. Pediatr Hematol Oncol 17(1):1–3. https://doi.org/10.1080/088800100276596. PMID: 10689708
Sayed DM, el-Attar MM, Hussein AA (2009) Evaluation of flow cytometric immunophenoty** and DNA analysis for detection of malignant cells in serosal cavity fluids. Diagn Cytopathol 37(7):498–504. https://doi.org/10.1002/dc.21047. PMID: 19217060
Shirai T, Hirose S, Okada T et al (1991) CD5+ B cells in autoimmune disease and lymphoid malignancy. Clin Immunol Immunopathol 59(2):173–186. https://doi.org/10.1016/0090-1229(91)90016-4. PMID: 1706969
Stacchini A, Aliberti S, Demurtas A et al (2019) Flow cytometry identification of nonhemopoietic neoplasms during routine immunophenoty**. Int J Lab Hematol 41(2):208–217. https://doi.org/10.1111/ijlh.12946. Epub 2018 Nov 27. PMID: 30480372
Stetler-Stevenson M, Arthur DC, Jabbour N et al (2001) Diagnostic utility of flow cytometric immunophenoty** in myelodysplastic syndrome. Blood 98(4):979–987. https://doi.org/10.1182/blood.v98.4.979. PMID: 11493442
Swerdlow SH, Campo E, Harris NL et al (eds) (2017) World Health Organization Classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. International Agency for Research on Cancer, Lyon
Takenokuchi M, Kawano S, Nakamachi Y et al (2012) FLT3/ITD associated with an immature immunophenotype in PML-RARα leukemia. Hematol Rep 4(4):e22. https://doi.org/10.4081/hr.2012.e22. Epub 2012 Oct 16. PMID: 23355940; PMCID: PMC3555210
van de Loosdrecht AA, Alhan C, Béné MC et al (2009) Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 94(8):1124–1134. https://doi.org/10.3324/haematol.2009.005801. Epub 2009 Jun 22. PMID: 19546437; PMCID: PMC2719035
Weir EG, Borowitz MJ (2001) Flow cytometry in the diagnosis of acute leukemia. Semin Hematol 38(2):124–138. https://doi.org/10.1016/s0037-1963(01)90046-0. PMID: 11309694
Westers TM, Ireland R, Kern W et al (2012) Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia 26(7):1730–1741. https://doi.org/10.1038/leu.2012.30. Epub 2012 Feb 6. PMID: 22307178
Wood B (2006) 9-color and 10-color flow cytometry in the clinical laboratory. Arch Pathol Lab Med 130(5):680–690. https://doi.org/10.5858/2006-130-680-CACFCI. PMID: 16683886
Wood BL, Arroz M, Barnett D et al (2007) 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom 72(Suppl 1):S14–S22. https://doi.org/10.1002/cyto.b.20363. PMID: 17803189
Zakzok O, Elshanshory M, Zekri W et al (2022) Prognostic value of detection of CD99+, CD45− cells in peripheral blood by flow cytometry in children with Ewing sarcoma. Pediatr Blood Cancer 69(1):e29298. https://doi.org/10.1002/pbc.29298. Epub 2021 Aug 17. PMID: 34403190
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Li, W. (2023). Flow Cytometry in the Diagnosis of Hematological Neoplasms and Other Cancers. In: Rezaei, N. (eds) Handbook of Cancer and Immunology. Springer, Cham. https://doi.org/10.1007/978-3-030-80962-1_145-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-80962-1_145-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-80962-1
Online ISBN: 978-3-030-80962-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences